CART19-BE-01: A Multicenter Trial of ARI-0001 Cell Therapy in Patients with CD19


Journal

Molecular therapy : the journal of the American Society of Gene Therapy
ISSN: 1525-0024
Titre abrégé: Mol Ther
Pays: United States
ID NLM: 100890581

Informations de publication

Date de publication:
03 02 2021
Historique:
received: 09 07 2020
revised: 25 08 2020
accepted: 16 09 2020
pubmed: 4 10 2020
medline: 21 10 2021
entrez: 3 10 2020
Statut: ppublish

Résumé

We evaluated the administration of ARI-0001 cells (chimeric antigen receptor T cells targeting CD19) in adult and pediatric patients with relapsed/refractory CD19

Identifiants

pubmed: 33010231
pii: S1525-0016(20)30484-6
doi: 10.1016/j.ymthe.2020.09.027
pmc: PMC7854276
pii:
doi:

Substances chimiques

Antigens, CD19 0
Receptors, Chimeric Antigen 0

Banques de données

ClinicalTrials.gov
['NCT03144583']

Types de publication

Clinical Trial Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

636-644

Informations de copyright

Copyright © 2020 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights reserved.

Références

Blood. 2014 Jul 10;124(2):188-95
pubmed: 24876563
N Engl J Med. 2017 Mar 2;376(9):836-847
pubmed: 28249141
J Clin Oncol. 2014 Sep 20;32(27):3059-68
pubmed: 25113753
J Clin Oncol. 2020 Feb 10;38(5):415-422
pubmed: 31815579
Leukemia. 2007 Sep;21(9):1907-14
pubmed: 17611565
J Natl Compr Canc Netw. 2015 Oct;13(10):1240-79
pubmed: 26483064
Biol Blood Marrow Transplant. 2013 Jul;19(7):1059-64
pubmed: 23644077
Hemasphere. 2019 Feb 08;3(2):e174
pubmed: 31723815
Leukemia. 2012 Jun;26(6):1211-7
pubmed: 22290066
N Engl J Med. 2018 Feb 1;378(5):439-448
pubmed: 29385370
Blood. 2017 Oct 19;130(16):1800-1808
pubmed: 28774879
Blood. 2017 Jun 22;129(25):3322-3331
pubmed: 28408462
Br J Haematol. 2020 Jan;188(2):207-223
pubmed: 31566728
N Engl J Med. 2018 Jul 5;379(1):64-73
pubmed: 29972754
Lancet. 2015 Feb 7;385(9967):517-528
pubmed: 25319501
Blood. 2019 Apr 11;133(15):1652-1663
pubmed: 30728140
Cancer. 2010 Dec 15;116(24):5568-74
pubmed: 20737576
Front Immunol. 2020 Mar 20;11:482
pubmed: 32528460
N Engl J Med. 2016 Aug 25;375(8):740-53
pubmed: 27292104
Blood. 2008 Jun 15;111(12):5446-56
pubmed: 18216293
Blood. 2012 Sep 6;120(10):2032-41
pubmed: 22493293
Mol Ther Methods Clin Dev. 2018 Dec 06;12:134-144
pubmed: 30623002
N Engl J Med. 2017 Dec 28;377(26):2545-2554
pubmed: 29226764
Haematologica. 2010 Apr;95(4):589-96
pubmed: 20145276
N Engl J Med. 2018 Feb 1;378(5):449-459
pubmed: 29385376
N Engl J Med. 2017 Dec 28;377(26):2531-2544
pubmed: 29226797

Auteurs

Valentín Ortíz-Maldonado (V)

Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.

Susana Rives (S)

Department of Hematology/Oncology, Hospital Sant Joan de Déu, Barcelona, Spain; Institut de Recerca Pediàtrica Sant Joan de Déu, Barcelona, Spain.

Maria Castellà (M)

Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) , Barcelona, Spain.

Anna Alonso-Saladrigues (A)

Department of Hematology/Oncology, Hospital Sant Joan de Déu, Barcelona, Spain.

Daniel Benítez-Ribas (D)

Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) , Barcelona, Spain; Department of Immunology, Hospital Clínic de Barcelona, Barcelona, Spain.

Miguel Caballero-Baños (M)

Department of Immunology, Hospital Clínic de Barcelona, Barcelona, Spain.

Tycho Baumann (T)

Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) , Barcelona, Spain.

Joan Cid (J)

Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) , Barcelona, Spain; Apheresis & Cell Therapy Unit, Department of Hemotherapy and Hemostasis, Hospital Clínic de Barcelona, Barcelona, Spain.

Enric Garcia-Rey (E)

Banc de Sang i Teixits, Barcelona, Spain.

Cristina Llanos (C)

Clinical Research Unit, Fundació Sant Joan de Déu, Barcelona, Spain.

Montserrat Torrebadell (M)

Institut de Recerca Pediàtrica Sant Joan de Déu, Barcelona, Spain; Laboratory of Hematology, Hospital Sant Joan de Déu, Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER) , Barcelona, Spain.

Neus Villamor (N)

Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) , Barcelona, Spain; Hematopathology Unit, Hospital Clínic de Barcelona, Barcelona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain.

Eva Giné (E)

Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) , Barcelona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain.

Marina Díaz-Beyá (M)

Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) , Barcelona, Spain.

Laia Guardia (L)

Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.

Mercedes Montoro (M)

Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.

Albert Català (A)

Department of Hematology/Oncology, Hospital Sant Joan de Déu, Barcelona, Spain; Institut de Recerca Pediàtrica Sant Joan de Déu, Barcelona, Spain.

Anna Faura (A)

Department of Hematology/Oncology, Hospital Sant Joan de Déu, Barcelona, Spain.

E Azucena González (EA)

Department of Immunology, Hospital Clínic de Barcelona, Barcelona, Spain.

Marta Español-Rego (M)

Department of Immunology, Hospital Clínic de Barcelona, Barcelona, Spain.

Nela Klein-González (N)

Department of Immunology, Hospital Clínic de Barcelona, Barcelona, Spain.

Laia Alsina (L)

Clinical Immunology Platform Clínic-Sant Joan de Déu, Barcelona, Spain.

Pedro Castro (P)

Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) , Barcelona, Spain; Medical Intensive Care Unit, Hospital Clínic de Barcelona, Barcelona, Spain; University of Barcelona, Barcelona, Spain.

Iolanda Jordan (I)

Institut de Recerca Pediàtrica Sant Joan de Déu, Barcelona, Spain; University of Barcelona, Barcelona, Spain; Intensive Care Unit, Hospital Sant Joan de Déu, Barcelona, Spain.

Sara Fernández (S)

Medical Intensive Care Unit, Hospital Clínic de Barcelona, Barcelona, Spain.

Federico Ramos (F)

Department of Neurology, Hospital Sant Joan de Déu, Barcelona, Spain.

Guillermo Suñé (G)

Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) , Barcelona, Spain.

Unai Perpiñá (U)

Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) , Barcelona, Spain; Laboratory of Stem Cells and Regenerative Medicine, Department of Biomedicine, Production and Validation Center of Advanced Therapies (Creatio), University of Barcelona, Barcelona, Spain.

Josep M Canals (JM)

Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) , Barcelona, Spain; Laboratory of Stem Cells and Regenerative Medicine, Department of Biomedicine, Production and Validation Center of Advanced Therapies (Creatio), University of Barcelona, Barcelona, Spain.

Miquel Lozano (M)

Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) , Barcelona, Spain; Apheresis & Cell Therapy Unit, Department of Hemotherapy and Hemostasis, Hospital Clínic de Barcelona, Barcelona, Spain; University of Barcelona, Barcelona, Spain.

Esteve Trias (E)

Advanced Therapies Unit, Hospital Clínic de Barcelona, Barcelona, Spain.

Andrea Scalise (A)

Department of Pharmacology, Hospital Clínic de Barcelona, Barcelona, Spain.

Sara Varea (S)

Department of Pharmacology, Hospital Clínic de Barcelona, Barcelona, Spain.

Joaquín Sáez-Peñataro (J)

University of Barcelona, Barcelona, Spain; Department of Pharmacology, Hospital Clínic de Barcelona, Barcelona, Spain.

Ferran Torres (F)

Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) , Barcelona, Spain; Department of Pharmacology, Hospital Clínic de Barcelona, Barcelona, Spain.

Gonzalo Calvo (G)

Advanced Therapies Unit, Hospital Clínic de Barcelona, Barcelona, Spain; Department of Pharmacology, Hospital Clínic de Barcelona, Barcelona, Spain.

Jordi Esteve (J)

Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) , Barcelona, Spain; University of Barcelona, Barcelona, Spain; Institute of Research Josep Carreras, Barcelona, Spain.

Álvaro Urbano-Ispizua (Á)

Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) , Barcelona, Spain; University of Barcelona, Barcelona, Spain; Institute of Research Josep Carreras, Barcelona, Spain.

Manel Juan (M)

Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) , Barcelona, Spain; Department of Immunology, Hospital Clínic de Barcelona, Barcelona, Spain; Clinical Immunology Platform Clínic-Sant Joan de Déu, Barcelona, Spain; University of Barcelona, Barcelona, Spain; Advanced Therapies Unit, Hospital Clínic de Barcelona, Barcelona, Spain. Electronic address: mjuan@clinic.cat.

Julio Delgado (J)

Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) , Barcelona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain; University of Barcelona, Barcelona, Spain. Electronic address: jdelgado@clinic.cat.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH